In the Pipeline
Healio spoke with expert rheumatologists about what they’re most excited for coming down the pipeline in ankylosing spondylitis, axial spondylarthritis and psoriatic arthritis.
In his video, Devon Charlton, MD, rheumatologist at University of Pittsburgh Medical Center, focused on exciting agents in the pipeline for psoriatic arthritis.
In his video, Delamo I. Bekele, MBBS, clinical rheumatologist and assistant professor of medicine at Mayo Clinic, discussed the “explosion of biologic options” in recent years, including TNF and non-TNF inhibitors, oral JAK inhibitors and IL-17 inhibitors.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.